We are live on
!
Find out more
Alkeon Capital Management Portfolio holdings
AUM
$59.5B
1-Year Est. Return
51.63%
This Fund
S&P 500
This Quarter
Est. Return
+23.56%
1 Year Est. Return
+51.63%
3 Year Est. Return
+162.63%
5 Year Est. Return
+168.42%
10 Year Est. Return
+1,374.92%
AUM
$61.4B
AUM Growth
+$7.43B
(+14%)
Cap. Flow
-$1B
Cap. Flow
% of AUM
-1.63%
Top 10 Holdings %
Top 10 Hldgs %
56.32%
Holding
179
New
34
Increased
69
Reduced
34
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$237M |
| 2 |
Twilio
TWLO
|
+$215M |
| 3 |
Global Payments
GPN
|
+$177M |
| 4 |
Pinterest
PINS
|
+$176M |
| 5 |
Atlassian
TEAM
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASML
ASML
|
+$259M |
| 2 |
Mercado Libre
MELI
|
+$194M |
| 3 |
Fidelity National Information Services
FIS
|
+$143M |
| 4 |
JOYY
JOYY Inc
JOYY
|
+$123M |
| 5 |
Lowe's Companies
LOW
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.46% |
| 2 | Consumer Discretionary | 7.5% |
| 3 | Communication Services | 4.16% |
| 4 | Financials | 3.26% |
| 5 | Healthcare | 2.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IGMS
101
DELISTED
IGM Biosciences
IGMS
| $92.8M | 0.15% |
1,050,984
+122,184
| +13% | +$8.59M |
|
102
JFrog
FROG
$10.8B
| $81.8M | 0.13% |
1,302,404
+2,404
| +0.2% | +$168K |
|
|
DAY
103
DELISTED
Dayforce
DAY
| $76.8M | 0.13% |
720,767
-599,233
| -45% | -$56.6M |
|
|
TPTX
104
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $76.5M | 0.12% |
627,951
+150,951
| +32% | +$16.5M |
|
105
Alnylam Pharmaceuticals
ALNY
$29.3B
| $75.7M | 0.12% |
582,085
+141,109
| +32% | +$18.8M |
|
106
Restaurant Brands International
QSR
$25.8B
| $73.9M | 0.12% |
1,208,776
+1,493
| +0.1% | +$87.1K |
|
107
Martin Marietta Materials
MLM
$33B
| $72.6M | 0.12% |
255,684
-34,278
| -12% | -$9.13M |
|
108
PMV Pharmaceuticals
PMVP
$63.5M
| $69.3M | 0.11% |
1,127,151
+652,151
| +137% | +$25.6M |
|
109
DoorDash
DASH
$93.7B
| $64.4M | 0.1% |
+451,011
| New | +$72M |
|
|
K
110
CALL
DELISTED
Kellanova
K
| $62.2M | 0.1% |
+1,065,000
| New | +$64M |
|
|
AKRO
111
DELISTED
Akero Therapeutics
AKRO
| $59M | 0.1% |
2,287,630
+6,923
| +0.3% | +$193K |
|
112
CALL
General Mills
GIS
$19.7B
| $58.8M | 0.1% |
+1,000,000
| New | +$60.5M |
|
113
Northrop Grumman
NOC
$81.2B
| $58.2M | 0.09% |
191,130
-134,580
| -41% | -$41.2M |
|
|
ALTR
114
DELISTED
Altair Engineering Inc
ALTR
| $51M | 0.08% |
876,615
+1,615
| +0.2% | +$81.4K |
|
115
NXP Semiconductors
NXPI
$60.4B
| $48.6M | 0.08% |
305,639
-184,361
| -38% | -$27.2M |
|
116
Micron Technology
MU
$991B
| $48.1M | 0.08% |
639,697
-400,000
| -38% | -$24.1M |
|
|
MRSN
117
DELISTED
Mersana Therapeutics
MRSN
| $48M | 0.08% |
72,193
+10,193
| +16% | +$5.67M |
|
|
GTM
118
ZoomInfo Technologies
GTM
$1.22B
| $46.4M | 0.08% |
+962,490
| New | +$41.5M |
|
|
KLRS
119
Kalaris Therapeutics
KLRS
$96.8M
| $42.2M | 0.07% |
47,696
| – | – |
|
120
Karyopharm Therapeutics
KPTI
$48M
| $41.3M | 0.07% |
177,761
+33,434
| +23% | +$7.75M |
|
121
Beam Therapeutics
BEAM
$2.84B
| $40.8M | 0.07% |
500,000
| – | – |
|
|
PLAN
122
DELISTED
Anaplan, Inc.
PLAN
| $39.9M | 0.06% |
+555,000
| New | +$36.1M |
|
|
DCPH
123
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $38.3M | 0.06% |
670,975
| – | – |
|
124
Keros Therapeutics
KROS
$221M
| $36.8M | 0.06% |
522,121
+492,121
| +1,640% | +$31M |
|
125
Oric Pharmaceuticals
ORIC
$1.4B
| $30.4M | 0.05% |
898,061
+595,000
| +196% | +$17.1M |
|
Similar funds
QCM
NAMI
Alkeon Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, Alkeon Capital Management held 179 positions worth $61.4B, up 14% from $54B the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Alkeon Capital Management's Q4 2020 filing shows 34 new, 69 increased, 34 reduced and 16 closed positions. Its largest new stake was Atlassian: 791,723 shares worth $185M. The largest sale was ASML, an estimated $259M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Alkeon Capital Management's largest Q4 2020 buy was Atlassian: 791,723 shares worth $185M.
- Alkeon Capital Management added most to Alibaba in Q4 2020, an estimated $237M increase.
- Alkeon Capital Management's biggest Q4 2020 reduction was Mercado Libre, cutting an estimated $194M.
- Alkeon Capital Management fully exited ASML in Q4 2020, selling an estimated $259M.
- Alkeon Capital Management's ten largest holdings make up 56% of its $61.4B portfolio in Q4 2020.
- Alkeon Capital Management opened 34 new positions and closed 16 in Q4 2020.
- Alkeon Capital Management's portfolio value rose 14% quarter-over-quarter to $61.4B.
Based on Alkeon Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.